(19)
(11) EP 2 640 704 A1

(12)

(43) Date of publication:
25.09.2013 Bulletin 2013/39

(21) Application number: 11785266.5

(22) Date of filing: 11.11.2011
(51) International Patent Classification (IPC): 
C07D 217/06(2006.01)
C07D 405/12(2006.01)
C07D 409/14(2006.01)
C07D 471/04(2006.01)
A61K 31/496(2006.01)
A61K 31/4725(2006.01)
A61P 37/00(2006.01)
A61P 35/00(2006.01)
C07D 401/12(2006.01)
C07D 409/12(2006.01)
C07D 413/12(2006.01)
A61K 31/4375(2006.01)
A61K 31/472(2006.01)
A61P 29/00(2006.01)
A61P 9/00(2006.01)
(86) International application number:
PCT/US2011/060411
(87) International publication number:
WO 2012/067963 (24.05.2012 Gazette 2012/21)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 15.11.2010 US 413646 P

(71) Applicant: Abbvie Inc.
North Chicago, IL 60064 (US)

(72) Inventors:
  • CURTIN, Michael L.
    Pleasant Prairie, Wisconsin 53158 (US)
  • SORENSEN, Bryan K.
    Antioch, Illinois 60002 (US)
  • HEYMAN, Howard R.
    Deerfield, Illinois 60015 (US)
  • CLARK, Richard F.
    Gurnee, Illinois 60031 (US)
  • MICHAELIDES, Michael
    Libertyville, Illinois 60048 (US)
  • TSE, Chris
    Libertyville, Illinois 60048 (US)

(74) Representative: Modiano, Micaela Nadia et al
Modiano & Partners (DE) Thierschstrasse 11
80538 München
80538 München (DE)

   


(54) NAMPT INHIBITORS